Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 12:02 pm Unchanged | 2023-12-29 | 13G | Akili, Inc. AKLI | BAILLIE GIFFORD & CO | 4,665,795 5.960% | 0 (Unchanged) | Filing History |
| 2024-01-29 11:55 am Sale | 2023-12-29 | 13G | Affirm Holdings, Inc. AFRM | BAILLIE GIFFORD & CO | 20,467,614 8.450% | -2,236,095![]() (-9.85%) | Filing History |
| 2024-01-29 11:52 am Sale | 2023-12-29 | 13G | Adaptimmune Therapeutics plc ADAPY | BAILLIE GIFFORD & CO | 95,472,840 7.010% | -7,546,794![]() (-7.33%) | Filing History |
| 2024-01-29 11:47 am Purchase | 2023-12-29 | 13G | AbCellera Biologics Inc. ABCL | BAILLIE GIFFORD & CO | 24,044,796 8.290% | 4,348,061![]() (+22.08%) | Filing History |
| 2024-01-29 11:43 am Sale | 2023-12-29 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 7,919,976 7.600% | -682,259![]() (-7.93%) | Filing History |
| 2024-01-29 10:53 am Purchase | 2023-12-29 | 13G | Nanobiotix S.A. NBTX | BAILLIE GIFFORD & CO | 2,869,030 6.210% | 1,355,823![]() (+89.60%) | Filing History |
| 2024-01-29 10:49 am Purchase | 2023-12-29 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 45,654,527 11.970% | 867,781![]() (+1.94%) | Filing History |
| 2024-01-29 10:44 am Purchase | 2023-12-29 | 13G | Mobileye Global Inc. MBLY | BAILLIE GIFFORD & CO | 8,424,283 8.900% | 2,241,922![]() (+36.26%) | Filing History |
| 2024-01-29 10:40 am Sale | 2023-12-29 | 13G | MercadoLibre, Inc. MELI | BAILLIE GIFFORD & CO | 5,383,227 10.650% | -742,073![]() (-12.11%) | Filing History |
| 2024-01-29 10:32 am Sale | 2023-12-29 | 13G | Lemonade, Inc. LMND | BAILLIE GIFFORD & CO | 4,549,693 6.510% | -341,511![]() (-6.98%) | Filing History |
| 2024-01-29 10:25 am Sale | 2023-12-29 | 13G | Jumia Technologies AG JMIA | BAILLIE GIFFORD & CO | 18,606,508 9.200% | -146,476![]() (-0.78%) | Filing History |
| 2024-01-29 10:20 am Purchase | 2023-12-29 | 13G | Joby Aviation, Inc. JOBY | BAILLIE GIFFORD & CO | 56,320,441 8.090% | 56,320,441![]() (New Position) | Filing History |
| 2024-01-29 10:06 am Sale | 2023-12-29 | 13G | HashiCorp, Inc. HCP | BAILLIE GIFFORD & CO | 6,730,652 5.740% | -439,100![]() (-6.12%) | Filing History |
| 2024-01-29 10:00 am Purchase | 2023-12-29 | 13G | Guardant Health, Inc. GH | BAILLIE GIFFORD & CO | 6,178,812 5.240% | 6,178,812![]() (New Position) | Filing History |
| 2024-01-29 09:55 am Sale | 2023-12-29 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | BAILLIE GIFFORD & CO | 5,907,305 14.590% | -197,112![]() (-3.23%) | Filing History |
| 2024-01-29 09:50 am Purchase | 2023-12-29 | 13G | Duolingo, Inc. DUOL | BAILLIE GIFFORD & CO | 3,593,426 10.040% | 340,673![]() (+10.47%) | Filing History |
| 2024-01-26 10:49 am Sale | 2023-12-29 | 13G | Recursion Pharmaceuticals, Inc. RXRX | BAILLIE GIFFORD & CO | 24,179,504 11.610% | -641,346![]() (-2.58%) | Filing History |
| 2024-01-26 10:45 am Sale | 2023-12-29 | 13G | Shopify Inc. SHOP | BAILLIE GIFFORD & CO | 64,164,758 5.320% | -8,283,203![]() (-11.43%) | Filing History |
| 2024-01-26 09:19 am Sale | 2023-12-29 | 13G | STAAR Surgical Company STAA | BAILLIE GIFFORD & CO | 4,448,208 9.110% | -792,248![]() (-15.12%) | Filing History |
| 2024-01-26 09:16 am Purchase | 2023-12-29 | 13G | Sprout Social, Inc. SPT | BAILLIE GIFFORD & CO | 4,114,040 8.430% | 4,114,040![]() (New Position) | Filing History |

